Ausgabe 9/2019
Inhalt (6 Artikel)
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors
Mauro Cives, Eleonora Pelle’, Davide Quaresmini, Barbara Mandriani, Marco Tucci, Franco Silvestris
Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors
Mohamad Bassam Sonbol, Thorvardur R. Halfdanarson
Carcinoid Syndrome: Updates and Review of Current Therapy
Kira Oleinikov, Shani Avniel-Polak, David J. Gross, Simona Grozinsky-Glasberg
A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers
Advanced Imaging Modalities to Monitor for Cardiotoxicity
Andreas Seraphim, Mark Westwood, Anish N. Bhuva, Tom Crake, James C. Moon, Leon J. Menezes, Guy Lloyd, Arjun K. Ghosh, Sarah Slater, Heather Oakervee, Charlotte H. Manisty
Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm
Adam B. Weiner, Oluwarotimi S. Nettey, Alicia K. Morgans